Skip to Content

Petlife Pharmaceuticals Inc

Rating as of

Company Profile

Business Description

Petlife Pharmaceuticals Inc specializes in the research, development, sales, and support of advanced drugs and nutraceuticals for pet cancer and autoimmune related diseases such as arthritis. It develops potentiated veterinary cancer medications and nutraceuticals, under its tradename Vitalzul based on Escozine formula. The Vitalzul is a polarized, bioactive peptide extracted from the Blue Caribbean Scorpion (Rhopularus Princeps), which contains amino acids, proteins, and minerals.

38 West Main Street, 6th Floor
Hancock, MD, 21750
T +1 844 473-8543
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Feb 28, 2018
Fiscal Year End Aug 31, 2018
Stock Type Distressed
Employees 1